Pinnacle Associates’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$506K Sell
854
-151
-15% -$75.2K 0.01% 658
2025
Q4
$490K Buy
1,005
+195
+24% +$90.8K 0.01% 656
2025
Q3
$340K Sell
810
-50
-6% -$16.8K ﹤0.01% 719
2025
Q2
$247K Buy
860
+50
+6% +$14.9K ﹤0.01% 785
2025
Q1
$250K Hold
810
﹤0.01% 756
2024
Q4
$286K Buy
+810
New +$298K ﹤0.01% 729
2024
Q3
Sell
-910
Closed -$290K 851
2024
Q2
$290K Sell
910
-50
-5% -$13.2K ﹤0.01% 695
2024
Q1
$221K Buy
+960
New +$217K ﹤0.01% 778
2018
Q1
Sell
-2,915
Closed -$431K 713
2017
Q4
$431K Sell
2,915
-1,060
-27% -$135K 0.01% 518
2017
Q3
$466K Sell
3,975
-140
-3% -$17.9K 0.01% 503
2017
Q2
$534K Sell
4,115
-755
-16% -$94.2K 0.01% 495
2017
Q1
$659K Sell
4,870
-9,309
-66% -$1.41M 0.01% 460
2016
Q4
$2.03M Sell
14,179
-670
-5% -$85.5K 0.04% 303
2016
Q3
$1.75M Sell
14,849
-8,868
-37% -$1.07M 0.04% 317
2016
Q2
$2.51M Sell
23,717
-18,723
-44% -$2.09M 0.05% 272
2016
Q1
$4.73M Buy
42,440
+30
+0.1% +$3.8K 0.1% 203
2015
Q4
$6.64M Sell
42,410
-1,435
-3% -$209K 0.14% 158
2015
Q3
$5.75M Sell
43,845
-1,376
-3% -$221K 0.13% 171
2015
Q2
$7.87M Sell
45,221
-3,215
-7% -$578K 0.15% 149
2015
Q1
$8.35M Buy
+48,436
New +$7.38M 0.16% 145

Other funds holding UTHR